This study represents the first in vivo validation of a hub/driver gene and subnetwork predicted by integrative network analyses of human postmortem sporadic LOAD brain and suggests that reduction of TYROBP level or inhibition of its activity could represent a potential therapeutic target for AD prevention and/or treatment. The gene discussed is TYROBP; the disease is Alzheimer disease.